CD14 Blood–CSF barrier ERRα Innate immune system Choroid plexus Treatment response Animal model Cytokines Aquaporin-4 antibody Toll-like receptor Cancer immunotherapy Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Disease modifying treatments Collapsing response mediator protein Estradiol NMOSD Neurological immune-related adverse events MOG Blood-brain barriers Reproductive assistance Adverse events Neurite outgrowth Encephalitis Myelitis Rituximab LAT1 Prognosis Microenvironment Hippocampus Neuroinflammation Autoimmune diseases Lateral diffusion Autoimmune encephalitis Cerebrospinal fluid Aquaporin-4 Breastfeeding MOG antibodies Jaundice Autoantibodies Relapses MOG-IgG associated disorders MOGAD Embryo Aquaporin-4-IgG AQP4-IgG Neuromyelitis optica CP Neuroscience Pregnancy Amino acid Meninges Circadian clock Central nervous system Astrocyte CP Molecular biology MRI Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation GSK-3β Post-partum Claudin CRMP5 B cells Adult neurogenesis Connexins Optic neuritis Blood brain barrier Biobank Bright Immune checkpoint inhibitors Drosophila Influx constant Glutamate Anti-GFAP encephalomyelitis Children Neuraxial analgesia Gunn Database Neural antibodies Area postrema syndrome Myelin oligodendrocyte glycoprotein Clinically isolated syndrome CIS Multiple sclerosis MOGAD Blood-brain barrier Registry Cilia Cannabinoid receptor type 2 Aquaporin-4 antibodies Longitudinally extensive transverse myelitis Endocannabinoid system Blood–brain barrier COVID-19 Multiple sclerosis MS Immunosuppressant Disease-modifying treatments GABA Cancer Glia Demyelination Bone Biomarkers Ependymal cell Microglia